|
Author:
Ying Wu, MyungSam Cho, David Shore, Manki Song, JungAh Choi, Tao Jiang, Yong-Qiang Deng, Melissa Bourgeois, Lynn Almli, Hua Yang, Li-Mei Chen, Yi Shi, Jianxu Qi, An Li, Kye Sook Yi, MinSeok Chang, Jin Soo Bae, HyunJoo Lee, JiYoung Shin, James Stevens, SeoungSuh Hong, Cheng-Feng Qin, George F. Gao, Shin Jae Chang and Ruben O. Donis,
Date:
2016-06-05
[Abstract] Heamagglutination is inhibited when antibodies are present because antibodies to the influenza virus will prevent attachment of the virus to red blood cells. The highest dilution of antibody that prevents hemagglutination is called the HI titer. Human monoclonal antibodies generated from single human B cells were tested to characterize their ability to inhibit hemagglutination against virus A/California/07/2009 (H1N1) and A/Brisbane/10/2007 (H3N2).
[摘要] 当存在抗体时，凝血抑制被抑制，因为针对流感病毒的抗体将阻止病毒附着于红细胞。 防止血细胞凝集的抗体的最高稀释度称为HI滴度。 测试从单个人B细胞产生的人单克隆抗体，以表征其抑制关于病毒A/California/07/2009（H1N1）和A/Brisbane/10/2007（H3N2）的凝血的能力。
|